APA (7th ed.) Citation

Sakai, F., Suzuki, N., Kim, B., Tatsuoka, Y., Imai, N., Ning, X., . . . Koga, N. (2021). Efficacy and safety of fremanezumab for episodic migraine prevention: Multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group trial in Japanese and Korean patients. Headache: The Journal of Head & Face Pain, 61(7), 1102. https://doi.org/10.1111/head.14178

Chicago Style (17th ed.) Citation

Sakai, Fumihiko, et al. "Efficacy and Safety of Fremanezumab for Episodic Migraine Prevention: Multicenter, Randomized, Double‐blind, Placebo‐controlled, Parallel‐group Trial in Japanese and Korean Patients." Headache: The Journal of Head & Face Pain 61, no. 7 (2021): 1102. https://doi.org/10.1111/head.14178.

MLA (9th ed.) Citation

Sakai, Fumihiko, et al. "Efficacy and Safety of Fremanezumab for Episodic Migraine Prevention: Multicenter, Randomized, Double‐blind, Placebo‐controlled, Parallel‐group Trial in Japanese and Korean Patients." Headache: The Journal of Head & Face Pain, vol. 61, no. 7, 2021, p. 1102, https://doi.org/10.1111/head.14178.